The global non-invasive hemodynamic monitoring market was valued at USD 1.43 Billion in 2025 and is expected to grow at a CAGR of 6.80%, reaching USD 2.76 Billion by 2035. The market growth is driven by the increasing adoption of advanced monitoring technologies, the growing demand for minimally invasive procedures, and the rising prevalence of cardiovascular disorders. The expansion of applications in critical care and perioperative settings, combined with technological innovations that enhance accuracy and usability, is expected to propel market value. Growing healthcare expenditure and wider integration of digital health solutions will further aid growth during the forecast period.
Base Year
Historical Period
Forecast Period
According to the World Health Organization, sepsis causes an estimated 11 million deaths annually, and along with the rising burden of cardiovascular diseases, it is accelerating the adoption of non-invasive hemodynamic monitoring, thereby fueling market growth.
The market is experiencing robust growth driven by the rising burden of chronic diseases, technological advancements, and increasing adoption of minimally invasive monitoring solutions.
Ongoing innovations, product enhancements, and strategic initiatives by leading industry participants are significantly contributing to market expansion and broader clinical adoption.
Compound Annual Growth Rate
6.8%
Value in USD Billion
2026-2035
*this image is indicative*
Non-invasive hemodynamic monitoring has gained prominence as an advanced approach that enables clinicians to assess cardiovascular function with greater safety, accuracy, and patient comfort. It plays an essential role in critical care, perioperative settings, and emergency medicine, supporting timely and informed clinical decisions. The market was valued at USD 1.43 Billion in 2025, driven by rising demand for improved patient outcomes, growing preference for less intrusive technologies, and increasing adoption across hospitals and specialty clinics. Technological advancements, an expanding geriatric population, and a heightened focus on early disease detection continue to propel its growth, strengthening its significance in modern healthcare.
Rising Cardiovascular Disease Burden to Drive the Growth in the Market
The growing global burden of cardiovascular diseases is a significant driver of demand for advanced hemodynamic monitoring solutions. According to the World Heart Federation, more than half a billion people worldwide were affected by cardiovascular conditions, leading to 20.5 million deaths in 2021, nearly one-third of total global deaths, marking an increase from 12.1 million in previous estimates. These alarming statistics underscore the urgent need for reliable monitoring technologies to support timely diagnosis and effective management. This trend is expected to strongly propel market growth in the coming years.
Some of the trends in the market include AI-driven innovations and the rising adoption of wearable hemodynamic monitoring solutions.
AI-Powered Innovations are Likely to Enhance the Market Expansion
The growing adoption of artificial intelligence in advanced patient monitoring systems is redefining non-invasive hemodynamic monitoring. In April 2025, BD introduced the HemoSphere Alta platform, integrating predictive AI algorithms to help clinicians proactively manage blood pressure instability and improve blood flow. Equipped with features such as a cerebral autoregulation index, non-invasive sensors, and intuitive hands-free controls, this launch marked a significant advancement in personalized patient care. Such technological breakthroughs are expected to accelerate adoption and substantially enhance the market’s overall growth trajectory.
Growing Adoption of Wearable Solutions to Boost Non-Invasive Hemodynamic Monitoring Market Value
The increasing integration of wearable technologies into patient monitoring has emerged as a key trend, enabling real-time and non-invasive tracking of cardiovascular parameters. In July 2025, Terumo Health Outcomes entered a U.S. distribution agreement with Caretaker Medical to provide its VitalStream® platform, a wearable solution that delivers continuous, beat-by-beat hemodynamic data for earlier detection of critical changes. Such advancements reflect a shift toward smarter, wire-free monitoring approaches, ultimately supporting better clinical decisions and enhancing overall market growth.
Ultrasound/Doppler-Based Monitoring Set to Lead the Market by Technology
The market is segmented by technology, including ultrasound/doppler-based monitoring, bioreactance-based monitoring, impedance-based monitoring, and algorithm-enhanced/hybrid monitoring. Among these, ultrasound/doppler-based monitoring is expected to command the largest share owing to its growing use in critical care and surgical environments. For instance, in June 2025, Flosonics Medical expanded its FDA-cleared wearable doppler ultrasound patch, FloPatch, to the Mount Sinai Hospital, a renowned hospital chain in the East Coast of United States. Such expanded applications reflect strong clinical adoption and highlights the rising preference for real-time, non-invasive, and individualized fluid management solutions.
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is emerging as the leading contributor. Strong adoption is driven by advanced healthcare infrastructure, high awareness, and continuous product innovation. For example, in April 2025, BD (Becton, Dickinson and Company) launched its HemoSphere Alta™ advanced monitoring platform in the United States. Featuring artificial intelligence-driven algorithms and non-invasive sensors, the solution enhances predictive capabilities and optimizes patient management. Such innovations reinforce North America’s position at the forefront of market growth.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
GE Healthcare plays a leading role in advancing patient monitoring solutions with a strong focus on accuracy, connectivity, and clinical efficiency. Its portfolio includes the Carescape™ One, B1x5M/B1x5P, and B650 monitors, designed to provide continuous, reliable data across varying levels of care. With innovations in non-invasive blood pressure monitoring, vital signs systems, and connectivity platforms, the company enables clinicians to make informed, timely decisions that improve patient outcomes.
Edwards Lifesciences Corporation is a leading developer of advanced hemodynamic monitoring solutions designed to support individualized patient management. Its HemoSphere platform integrates non-invasive cuffs, sensors, and tissue oximetry into a unified system, enhancing real-time monitoring of pressure, flow, and oxygenation. Products such as the ClearSight finger cuff, ForeSight tissue oximetry sensor, and Acumen IQ cuff provide continuous, non-invasive insights that help clinicians detect hemodynamic instability early and optimize patient outcomes.
Baxter AG has strengthened its role in advanced patient monitoring through its starling fluid management monitoring system, which leverages patented Bioreactance technology to deliver precise, non-invasive hemodynamic insights. Designed to support individualized fluid therapy, the system enables real-time assessment of cardiac output and fluid responsiveness, helping clinicians optimize treatment decisions while reducing risks associated with invasive methods and improving patient outcomes in critical care.
ICU Medical, Inc. delivers advanced hemodynamic monitoring solutions that enhance patient care across critical settings. Its portfolio includes the Cogent™ 2-in-1 Hemodynamic Monitoring System, CardioFlo™ Hemodynamic Monitoring Sensor, and SafeSet™ Blood Sampling System, along with Transpac™ IV Disposable Pressure Transducers and LogiCal™ Pressure Monitoring Systems. By integrating minimally invasive technologies with efficient pressure monitoring and closed blood sampling, the company strengthens clinical decision-making and infection control in patient management.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Getinge AB, Masimo Corporation, Mindray Bio-Medical Electronics Co., Ltd., and Nihon Kohden Corporation.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
Market Breakup by Clinical Application
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Clinical Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share